Topics discussedWhich segments and countries have recovered to pre-pandemic levels?Which segments are poised for strong growth post covid? What are these drivers?What domestic players have risen and are well positioned for sustainable growth?Post pandemic healthcare changesGetting ready to win in a new era of IVDPresenter: Chee Hew, Director, Data Analytics & Consulting, ClearstateDate &Time: 4:00 PM SGT / 9:00 am BST, 20th October 2022 Watch on demand
Case study How impactful is your exhibitor booth going to be at AACC? Navigating the complex dynamics of conference exhibitions is an investment, involving costs related to staff training and travel, marketing content, booth design, and added features and zones such as the inclusion of a medical corner. To justify these expenses and understand where to channel future… In-vitro diagnostics | Uncategorised | Global | IVD Gateway | LabPRO Plus | Size and Share Plus
Clearstate Insights Driving better diagnostic discovery for patients with Rebecca Middleton, vice chair of the participant panel at Genomics England In-vitro diagnostics | Next Generation Sequencing (NGS) | Uncategorised | Europe | IVD Gateway | Next Generation Sequencing (NGS)
Clearstate Insights Enabling faster diagnosis of rare diseases: Interview with HBA Support’s Rebecca Middleton In-vitro diagnostics | Next Generation Sequencing (NGS) | Uncategorised | Europe | IVD Gateway | Next Generation Sequencing (NGS)
Clearstate Insights The future of thalassemia care In-vitro diagnostics | Next Generation Sequencing (NGS) | IVD Gateway | Next Generation Sequencing (NGS)
IVD GatewayThe go-to source for tracking and understanding market size, share and trends in IVD. Granular break-out of data and comprehensive coverage of international and domestic suppliers’ brand share across Asia, Europe, Latin America and the Middle East. Find out more